Tuoxin Pharmaceuticals: Wholly-owned subsidiary obtains CNAS laboratory accreditation certificate.

date
15/09/2025
Tuoxin Pharmaceutical announced that its wholly-owned subsidiary, Henan Nucleotide Drug Research Institute Co., Ltd., recently received a laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment (CNAS). The institution's name is Henan Nucleotide Drug Research Institute Co., Ltd., with a testing center registration number of CNAS L23965. The certificate is valid from September 1, 2025, to August 31, 2031.